Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2020 Jul 13;17(14):5026.
doi: 10.3390/ijerph17145026.

Correlations of Clinical and Laboratory Characteristics of COVID-19: A Systematic Review and Meta-Analysis

Ramy Abou Ghayda  1   2 , Jinhee Lee  3 , Jun Young Lee  4 , Da Kyung Kim  5 , Keum Hwa Lee  6 , Sung Hwi Hong  2 , Young Joo Han  7 , Jae Seok Kim  4 , Jae Won Yang  4 , Andreas Kronbichler  8 , Lee Smith  9 , Ai Koyanagi  10   11 , Louis Jacob  10   12 , Jae Il Shin  6
Affiliations
Meta-Analysis

Correlations of Clinical and Laboratory Characteristics of COVID-19: A Systematic Review and Meta-Analysis

Ramy Abou Ghayda et al. Int J Environ Res Public Health. .

Abstract

(1) Background: The global threat of Coronavirus disease 2019 (COVID-19) continues. The diversity of clinical characteristics and progress are reported in many countries as the duration of the pandemic is prolonged. We aimed to perform a novel systematic review and meta-analysis focusing on findings about correlations between clinical characteristics and laboratory features of patients with COVID-19. (2) Methods: We analyzed cases of COVID-19 in different countries by searching PubMed, Embase, Web of Science databases and Google Scholar, from the early stage of the outbreak to late March. Clinical characteristics, laboratory findings, and treatment strategies were retrospectively reviewed for the analysis. (3) Results: Thirty-seven (n = 5196 participants) COVID-19-related studies were eligible for this systematic review and meta-analysis. Fever, cough and fatigue/myalgia were the most common symptoms of COVID-19, followed by some gastrointestinal symptoms which are also reported frequently. Laboratory markers of inflammation and infection including C-reactive protein (CRP) (65% (95% confidence interval (CI) 56-81%)) were elevated, while lymphocyte counts were decreased (63% (95% CI 47-78%)). Meta-analysis of treatment approaches indicated that three modalities of treatment were predominantly used in the majority of patients with a similar prevalence, including antiviral agents (79%), antibiotics (78%), and oxygen therapy (77%). Age was negatively correlated with number of lymphocytes, but positively correlated with dyspnea, number of white blood cells, neutrophils, and D-dimer. Chills had been proved to be positively correlated with chest tightness, lung abnormalities on computed tomography (CT) scans, neutrophil/lymphocyte/platelets count, D-dimer and CRP, cough was positively correlated with sputum production, and pulmonary abnormalities were positively correlated with CRP. White blood cell (WBC) count was also positively correlated with platelet counts, dyspnea, and neutrophil counts with the respective correlations of 0.668, 0.728, and 0.696. (4) Conclusions: This paper is the first systematic review and meta-analysis to reveal the relationship between various variables of clinical characteristics, symptoms and laboratory results with the largest number of papers and patients until now. In elderly patients, laboratory and clinical characteristics indicate a more severe disease course. Moreover, treatments such as antiviral agents, antibiotics, and oxygen therapy which are used in over three quarters of patients are also analyzed. The results will provide "evidence-based hope" on how to manage this unanticipated and overwhelming pandemic.

Keywords: COVID-19; clinical characteristics; correlation; laboratory findings; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Forest plot of clinical characteristics. Abbreviations: CI: confidence interval, n: number, I2: heterogeneity.
Figure 2
Figure 2
Forest plot of laboratory parameters and chest imaging. (a). Forest plot of laboratory findings. (b). Forest plot of chest imaging findings.
Figure 3
Figure 3
Forest plot of treatments. Abbreviations: CI: confidence interval, n: number, I2: heterogeneity.
See this image and copyright information in PMC

References

    1. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5. - DOI - PMC - PubMed
    1. Yaqian M., Lin W., Wen J., Chen G. Clinical and pathological characteristics of 2019 novel coronavirus disease (COVID-19): A systematic review. medRxiv. 2020 doi: 10.1101/2020.02.20.20025601. - DOI
    1. WHO WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19 - 11 March 2020. [(accessed on 28 February 2020)]; Available online: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-re....
    1. Hui D.S., Ng S.S. Recommended hospital preparations for future cases and outbreaks of novel influenza viruses. Expert Rev. Respir. Med. 2020;14:41–50. doi: 10.1080/17476348.2020.1683448. - DOI - PubMed
    1. Guan W.-J., Ni Z.-Y., Hu Y., Liang W.-H., Ou C.-Q., He J.-X., Liu L., Shan H., Lei C.-L., Hui D.S., et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020;382:1708–1720. doi: 10.1056/NEJMoa2002032. - DOI - PMC - PubMed

Substances